We have described a case in which inhibition of c-kit and PDGFRs tyrosine kinases by imatinib leads to hair depigmentation, thinning and delayed regrowth. These manifestations are reversible upon discontinuation of the drug and do not depend on hormonal changes.
Reversible hair depigmentation in a patient treated with imatinib / Stefania, Mariani; Elisabetta, Abruzzese; Basciani, Sabrina; Fiore, Daniela; Watanabe, Mikiko; Giovanni, Spera; Gnessi, Lucio. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - STAMPA. - 35:6(2011), pp. e64-e66. [10.1016/j.leukres.2010.11.028]
Reversible hair depigmentation in a patient treated with imatinib
Stefania Mariani;BASCIANI, Sabrina;FIORE, DANIELA;Agnese Persichetti;Mikiko Watanabe;GNESSI, Lucio
2011
Abstract
We have described a case in which inhibition of c-kit and PDGFRs tyrosine kinases by imatinib leads to hair depigmentation, thinning and delayed regrowth. These manifestations are reversible upon discontinuation of the drug and do not depend on hormonal changes.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
